Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glaukos (GKOS) Cash & Equivalents (2016 - 2025)

Glaukos (GKOS) has disclosed Cash & Equivalents for 13 consecutive years, with $90.8 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 46.46% to $90.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $90.8 million through Dec 2025, down 46.46% year-over-year, with the annual reading at $90.8 million for FY2025, 46.46% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $90.8 million at Glaukos, down from $98.2 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $169.6 million in Q4 2024, with the low at $42.5 million in Q1 2024.
  • Average Cash & Equivalents over 5 years is $101.0 million, with a median of $100.8 million recorded in 2021.
  • Peak annual rise in Cash & Equivalents hit 168.86% in 2025, while the deepest fall reached 46.46% in 2025.
  • Over 5 years, Cash & Equivalents stood at $100.7 million in 2021, then grew by 18.68% to $119.5 million in 2022, then fell by 21.8% to $93.5 million in 2023, then soared by 81.48% to $169.6 million in 2024, then crashed by 46.46% to $90.8 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $90.8 million, $98.2 million, and $100.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.